CYCC logo

Cyclacel Pharmaceuticals (CYCC) Income Tax

Annual Income Tax

-$3.00 M
+$1.72 M+36.49%

December 31, 2023


Summary


Performance

CYCC Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYCCexpensesmetrics:

Quarterly Income Tax

-$210.00 K
+$202.00 K+49.03%

September 30, 2024


Summary


Performance

CYCC Quarterly Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYCCexpensesmetrics:

TTM Income Tax

-$2.40 M
+$458.00 K+16.04%

September 30, 2024


Summary


Performance

CYCC TTM Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCYCCexpensesmetrics:

Income Tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

CYCC Income Tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.5%+50.2%+20.0%
3 y3 years-142.4%+84.1%+51.0%
5 y5 years-124.1%+84.1%+51.0%

CYCC Income Tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+36.5%at high+86.7%at high+51.0%
5 y5-year-142.4%+36.5%at high+86.7%-94.2%+51.0%
alltimeall time-101.8%+36.5%-72.1%+86.7%-413.5%+51.0%

Cyclacel Pharmaceuticals Income Tax History

DateAnnualQuarterlyTTM
Sep 2024
-
-$210.00 K(-49.0%)
-$2.40 M(-16.0%)
Jun 2024
-
-$412.00 K(-69.6%)
-$2.86 M(-5.7%)
Mar 2024
-
-$1.35 M(+220.9%)
-$3.03 M(+1.1%)
Dec 2023
-$3.00 M(-36.5%)
-$422.00 K(-36.8%)
-$3.00 M(-27.9%)
Sep 2023
-
-$668.00 K(+14.0%)
-$4.16 M(-7.7%)
Jun 2023
-
-$586.00 K(-55.6%)
-$4.50 M(-8.1%)
Mar 2023
-
-$1.32 M(-16.5%)
-$4.90 M(+3.9%)
Dec 2022
-$4.72 M(+26.5%)
-$1.58 M(+55.9%)
-$4.72 M(+11.9%)
Sep 2022
-
-$1.01 M(+3.0%)
-$4.21 M(+0.4%)
Jun 2022
-
-$984.00 K(-13.5%)
-$4.20 M(+0.5%)
Mar 2022
-
-$1.14 M(+5.6%)
-$4.18 M(+12.1%)
Dec 2021
-$3.73 M(+201.6%)
-$1.08 M(+8.0%)
-$3.73 M(+23.1%)
Sep 2021
-
-$998.00 K(+3.5%)
-$3.03 M(+31.0%)
Jun 2021
-
-$964.00 K(+40.3%)
-$2.31 M(+41.5%)
Mar 2021
-
-$687.00 K(+81.7%)
-$1.63 M(+32.1%)
Dec 2020
-$1.24 M(-4.6%)
-$378.00 K(+34.5%)
-$1.24 M(-5.4%)
Sep 2020
-
-$281.00 K(-1.7%)
-$1.30 M(+0.6%)
Jun 2020
-
-$286.00 K(-1.4%)
-$1.30 M(-1.6%)
Mar 2020
-
-$290.00 K(-35.3%)
-$1.32 M(+1.7%)
Dec 2019
-$1.30 M(-3.1%)
-$448.00 K(+64.1%)
-$1.30 M(+8.0%)
Sep 2019
-
-$273.00 K(-11.1%)
-$1.20 M(-2.3%)
Jun 2019
-
-$307.00 K(+14.6%)
-$1.23 M(-13.7%)
Mar 2019
-
-$268.00 K(-23.9%)
-$1.42 M(+6.4%)
Dec 2018
-$1.34 M(+34.6%)
-$352.00 K(+16.9%)
-$1.34 M(+12.8%)
Sep 2018
-
-$301.00 K(-40.0%)
-$1.19 M(+7.4%)
Jun 2018
-
-$502.00 K(+175.8%)
-$1.10 M(+26.9%)
Mar 2018
-
-$182.00 K(-9.0%)
-$869.00 K(-12.5%)
Dec 2017
-$993.00 K(-49.9%)
-$200.00 K(-8.7%)
-$993.00 K(-17.5%)
Sep 2017
-
-$219.00 K(-18.3%)
-$1.20 M(-16.3%)
Jun 2017
-
-$268.00 K(-12.4%)
-$1.44 M(-19.9%)
Mar 2017
-
-$306.00 K(-25.4%)
-$1.80 M(-9.4%)
Dec 2016
-$1.98 M(-7.5%)
-$410.00 K(-9.7%)
-$1.98 M(-4.2%)
Sep 2016
-
-$454.00 K(-27.5%)
-$2.07 M(-1.1%)
Jun 2016
-
-$626.00 K(+27.0%)
-$2.10 M(+11.8%)
Mar 2016
-
-$493.00 K(-1.0%)
-$1.87 M(-12.6%)
Dec 2015
-$2.14 M(-33.9%)
-$498.00 K(+4.2%)
-$2.14 M(-22.1%)
Sep 2015
-
-$478.00 K(+18.0%)
-$2.75 M(-9.0%)
Jun 2015
-
-$405.00 K(-46.9%)
-$3.03 M(-12.0%)
Mar 2015
-
-$763.00 K(-31.1%)
-$3.44 M(+6.0%)
Dec 2014
-$3.24 M
-$1.11 M(+47.7%)
-$3.24 M(+25.4%)
DateAnnualQuarterlyTTM
Sep 2014
-
-$750.00 K(-8.1%)
-$2.59 M(+0.8%)
Jun 2014
-
-$816.00 K(+43.4%)
-$2.57 M(+29.6%)
Mar 2014
-
-$569.00 K(+25.9%)
-$1.98 M(+18.6%)
Dec 2013
-$1.67 M(+23.6%)
-$452.00 K(-38.1%)
-$1.67 M(-10.0%)
Sep 2013
-
-$730.00 K(+217.4%)
-$1.85 M(+20.1%)
Jun 2013
-
-$230.00 K(-10.9%)
-$1.54 M(+7.1%)
Mar 2013
-
-$258.00 K(-59.5%)
-$1.44 M(+6.7%)
Dec 2012
-$1.35 M(+139.1%)
-$637.00 K(+52.0%)
-$1.35 M(+61.6%)
Sep 2012
-
-$419.00 K(+229.9%)
-$836.00 K(+54.0%)
Jun 2012
-
-$127.00 K(-24.4%)
-$543.00 K(+0.2%)
Mar 2012
-
-$168.00 K(+37.7%)
-$542.00 K(-4.1%)
Dec 2011
-$565.00 K(-14.0%)
-$122.00 K(-3.2%)
-$565.00 K(-4.9%)
Sep 2011
-
-$126.00 K(0.0%)
-$594.00 K(-2.8%)
Jun 2011
-
-$126.00 K(-34.0%)
-$611.00 K(-14.5%)
Mar 2011
-
-$191.00 K(+26.5%)
-$715.00 K(+8.8%)
Dec 2010
-$657.00 K(-30.7%)
-$151.00 K(+5.6%)
-$657.00 K(-0.2%)
Sep 2010
-
-$143.00 K(-37.8%)
-$658.00 K(-8.6%)
Jun 2010
-
-$230.00 K(+72.9%)
-$720.00 K(-0.4%)
Mar 2010
-
-$133.00 K(-12.5%)
-$723.00 K(-23.7%)
Dec 2009
-$948.00 K(-45.8%)
-$152.00 K(-25.9%)
-$948.00 K(-8.3%)
Sep 2009
-
-$205.00 K(-12.0%)
-$1.03 M(-16.6%)
Jun 2009
-
-$233.00 K(-34.9%)
-$1.24 M(-13.4%)
Mar 2009
-
-$358.00 K(+50.4%)
-$1.43 M(-18.1%)
Dec 2008
-$1.75 M(-14.3%)
-$238.00 K(-42.1%)
-$1.75 M(-12.7%)
Sep 2008
-
-$411.00 K(-3.3%)
-$2.00 M(-1.1%)
Jun 2008
-
-$425.00 K(-37.0%)
-$2.02 M(-6.4%)
Mar 2008
-
-$675.00 K(+37.2%)
-$2.16 M(+6.0%)
Dec 2007
-$2.04 M(-9.1%)
-$492.00 K(+13.6%)
-$2.04 M(-4.4%)
Sep 2007
-
-$433.00 K(-23.1%)
-$2.13 M(-7.4%)
Jun 2007
-
-$563.00 K(+2.0%)
-$2.30 M(-5.5%)
Mar 2007
-
-$552.00 K(-5.8%)
-$2.44 M(+8.6%)
Dec 2006
-$2.25 M(+18.2%)
-$586.00 K(-2.8%)
-$2.25 M(+9.4%)
Sep 2006
-
-$603.00 K(-13.4%)
-$2.05 M(+0.1%)
Jun 2006
-
-$696.00 K(+93.3%)
-$2.05 M(+14.4%)
Mar 2006
-
-$360.00 K(-8.6%)
-$1.79 M(-5.6%)
Dec 2005
-$1.90 M(-101.1%)
-$394.00 K(-34.4%)
-$1.90 M(+26.2%)
Sep 2005
-
-$601.00 K(+37.2%)
-$1.51 M(+66.4%)
Jun 2005
-
-$438.00 K(-6.2%)
-$905.00 K(+93.8%)
Mar 2005
-
-$467.00 K
-$467.00 K
Jan 1994
$171.00 M(+72.2%)
-
-
Jan 1993
$99.30 M
-
-

FAQ

  • What is Cyclacel Pharmaceuticals annual income tax?
  • What is the all time high annual income tax for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals annual income tax year-on-year change?
  • What is Cyclacel Pharmaceuticals quarterly income tax?
  • What is the all time high quarterly income tax for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals quarterly income tax year-on-year change?
  • What is Cyclacel Pharmaceuticals TTM income tax?
  • What is the all time high TTM income tax for Cyclacel Pharmaceuticals?
  • What is Cyclacel Pharmaceuticals TTM income tax year-on-year change?

What is Cyclacel Pharmaceuticals annual income tax?

The current annual income tax of CYCC is -$3.00 M

What is the all time high annual income tax for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high annual income tax is $171.00 M

What is Cyclacel Pharmaceuticals annual income tax year-on-year change?

Over the past year, CYCC annual income tax has changed by +$1.72 M (+36.49%)

What is Cyclacel Pharmaceuticals quarterly income tax?

The current quarterly income tax of CYCC is -$210.00 K

What is the all time high quarterly income tax for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high quarterly income tax is -$122.00 K

What is Cyclacel Pharmaceuticals quarterly income tax year-on-year change?

Over the past year, CYCC quarterly income tax has changed by +$212.00 K (+50.24%)

What is Cyclacel Pharmaceuticals TTM income tax?

The current TTM income tax of CYCC is -$2.40 M

What is the all time high TTM income tax for Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals all-time high TTM income tax is -$467.00 K

What is Cyclacel Pharmaceuticals TTM income tax year-on-year change?

Over the past year, CYCC TTM income tax has changed by +$598.00 K (+19.96%)